ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases

Eur Respir J. 2020 Feb 6;55(2):1901208. doi: 10.1183/13993003.01208-2019. Print 2020 Feb.

Abstract

This European Respiratory Society/Thoracic Society of Australia and New Zealand statement outlines a review of the literature and expert opinion concerning the management of reproduction and pregnancy in women with airways diseases: asthma, cystic fibrosis (CF) and non-CF bronchiectasis. Many women with these diseases are now living into reproductive age, with some developing moderate-to-severe impairment of lung function in early adulthood. The statement covers aspects of fertility, management during pregnancy, effects of drugs, issues during delivery and the post-partum period, and patients' views about family planning, pregnancy and parenthood. The statement summarises current knowledge and proposes topics for future research, but does not make specific clinical recommendations.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Australia
  • Cystic Fibrosis* / therapy
  • Female
  • Fertility
  • Humans
  • New Zealand
  • Pregnancy
  • Reproduction*